Pricing Log in Create free account

Synlogic, Inc. (SYBX) vs Alaunos Therapeutics, Inc. (TCRT)

Synlogic, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Synlogic, Inc. and Alaunos Therapeutics, Inc. are of similar size ($6.7M and $6.4M). Synlogic, Inc. grew revenue faster over the last twelve months: 188.7% against −17.7%. Across the 13 metrics below, Synlogic, Inc. leads on 10 and Alaunos Therapeutics, Inc. on 3.

Valuation

Metric SYBX TCRT Biotechnology median
P/E n/m n/m 8.50
P/S 3.87 456.87 9.71
P/B 1.03 9.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.16 n/m 0.64
EV/Sales (0.24) 1,552.30 9.21
Earnings yield (6.00%) (72.62%) (33.15%)
Free cash flow yield (29.61%) (20.65%) (25.50%)

Profitability

Metric SYBX TCRT Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (5.32%) (185.95%) (56.36%)
Return on assets (4.25%) (128.30%) (48.04%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric SYBX TCRT Biotechnology median
Revenue growth (TTM) 188.74% (17.65%) 6.02%
EPS growth (last fiscal year) 95.83% 24.66% 30.26%
Revenue growth, 5-year CAGR (67.55%) (49.08%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SYBX TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.19 0.77 4.72
Net debt to EBITDA 3.66 0.33 0.96

Dividend

Metric SYBX TCRT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SYBX TCRT Biotechnology median
Market cap 6.68m 6.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack